Chief Financial Officer - IPO/Reverse Merger - Pharma/Healthcare/Medical Equipment

Purpose of the Role:

To lead and execute the financial, regulatory, and strategic process for achieving stock market listing through a reverse merger or other optimal structuring options. The CFO will play a pivotal role in integrating the private limited company with the listed entity, ensuring compliance, governance, valuation alignment, and seamless post-transaction operations within the next 12 months.

Key Responsibilities:

1. IPO/ Reverse Merger / Strategic Listing Execution:

2. Coordination with Professional Advisors:

Act as single point of contact with:

1. Investment Bankers / Merchant Bankers

2. Legal Advisors

3. Statutory & Peer Review Auditors

4. Valuers and Secretarial Auditors

- Coordinate due diligence, scheme drafting, filings, and approvals.

- Manage queries from regulators, exchanges, and shareholders.

3. Financial Integration & Reporting:

4. Corporate Governance & Listed Entity Compliance:

5. Capital Structure, Tax & Transaction Advisory:

6. Investor Relations & Market Communication:

7. Post-Merger Stabilization & Growth:

Qualifications & Experience:

- Chartered Accountant (CA) / MBA Finance / CFA.

- 13-18 years of experience in finance, accounting, and compliance.

- Mandatory experience in at least one reverse merger, amalgamation, or listed-company transaction.

- Strong exposure to manufacturing and trading sector financials.

- Hands-on experience dealing with SEBI, Stock Exchanges, and listed-company compliances.